Its regulation by IL-6 family factors and the role in cell proliferation and chronic inflammation highlight the JAK/STAT3 pathway’s importance in intestinal immunity and IBD (73, 74), suggesting precise STAT3 modulation as a novel IBD treatment strategy. Here, IL6 is linked to inflammatory bowel disease.